| Particulars |
| Company Name |
Gland Pharma Ltd |
| Face Value |
1 |
| BSE Code |
543245 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
16.48 |
| B.V. Rs |
656.10 |
| Sales Rs in Cr. |
4,552.09 |
| NP Rs in Cr. |
1,317.59 |
| NP Var% |
21.00 |
| Div% |
2,000.00 |
| CPS Rs |
90.70 |
| EPS Rs |
80.00 |
| Traded Value(Rs in Lakhs) |
6,700.50 |
| 52 Week High |
2,205.00 |
| 52 Week Low |
1,453.00 |
| Price BSE |
2,159.00 |
| Price NSE |
2,157.00 |
| Market Capital(Rs in Cr.) |
35,574.21 |
| P/C Ratio |
23.80 |
| P/E Ratio |
27.00 |
| Price Vs.BV |
3.29 |
| Latest Quarter |
| Year End |
202603 |
| Sales Rs in Cr. |
1,261.59 |
| NP Rs in Cr. |
420.45 |
| NP Var % |
45.00 |
| Trailing Twelve Months |
| Year End |
202603 |
| Sales |
4,347.71 |
| OPM |
34.13 |
| NP |
1,102.85 |
| NP Var% |
21.02 |
| EPS |
79.97 |
| PE |
27.00 |
|